Magnesium Oxide Tablet
NDC Package 84447-001-12

11-digit billing NDC: 84447000112

Package Information

Magnesium Oxide tablets is a medication used as Antacid. This formulation utilizes a tablet delivery system. Marketed by Belleview Biosciences, this product is identified by NDC 84447-001 and is authorized under FDA application M001.

Identification & Billing

NDC Package Code
84447-001-12
Package Description
120 mg in 1 BOTTLE, PLASTIC
Product Code
11-Digit Billing Format
84447000112
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Magnesium Oxide
Non-Proprietary Name
Magnesium Oxide
Substance Name
Magnesium Oxide
Dosage Form
Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Usage Information
This product is used as Antacid. Relievesacid indigestionupset stomach

Regulatory & Marketing

Labeler Name
Belleview Biosciences
Product Type
Human Otc Drug
FDA Application #
M001
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
04-01-2023
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 84447-001-12 identifies a specific commercial package of 120 mg in 1 bottle, plastic of Magnesium Oxide, a human over the counter drug labeled by Belleview Biosciences. This tablet is formulated for oral use and contains magnesium oxide as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Belleview Biosciences on April 01, 2023. The current certification is valid through December 31, 2026.

How is this Belleview Biosciences product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 84447000112. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
84447-001-12
11-Digit CMS (5-4-2)
84447-0001-12

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.